Vitruvian Shield SA

12/01/2026

Innovation Validated: Vitruvian Shield takes 3rd Place! 🥉

​I am proud to share that Vitruvian Shield has secured 3rd place in the Digital Health Summit at Funchal in Madeira

​This recognition is a powerful testament to our team’s dedication to pushing the boundaries of medical wearables and Decentralized Clinical Trials (DCTs).

In a field defined by rapid evolution, our platform stands out for its unique integration of high-fidelity hardware and sophisticated software—purpose-built for the future of healthcare.

https://youtu.be/s2aBgL0FuDg?si=5drDuBUBnVjRO0oF

Vitruvian Shield SA

The Digital Health Summit 2025 took place on December 10th and 11th at the University of Madeira -Colégio dos Jesuítas, in Funchal. This event brought togeth...

15/12/2025

We at Vitruvian Shield SA are honoured to announce that we secured 3rd Place at the Digital Health Summit 2025, hosted by – Health Innovation Hub at the University of Madeira in Funchal on 10–11 December 2025.

This summit brought together leading hospitals, organisations, startups, researchers, and healthcare innovation leaders to explore key advancements in digital transformation, AI in healthcare, cybersecurity, IoMT, and sustainable healthcare solutions.

We are grateful to the organisers, partners, and judges for recognising the value of our work. Earning this place among such a strong field of innovators underscores our team’s commitment to driving meaningful impact in health technology and patient-centred solutions.

Thank you to everyone who supported us along this journey — we look forward to accelerating collaboration and innovation in digital health.

12/10/2025

🚀 Vitruvian Shield SA Shield achieves Scientific Suitability Recognition from 🇵🇹

We’re proud to announce that Vitruvian Shield–PT LDA with headquarters at PCI · Creative Science Park Aveiro Region has been officially granted Scientific Suitability (Idoneidade Científica) recognition by the Agência Nacional de Inovação (ANI) — a key milestone in our journey to advance digital health, AI-driven research, and decentralized clinical trials.

This recognition, issued under Article 37-A of the Portuguese Investment Tax Code, validates Vitruvian Shield’s R&D capabilities in ICT applied to health, including:
💡 Remote patient monitoring (RPM)
💡 AI-enabled adaptive trial platforms
💡 Continuous digital biomarker discovery
💡 Integration of multi-sensor wearable technologies

It also opens the door to major national and European innovation instruments such as SIFIDE II, Portugal 2030, PRR Health Cluster, and Innosuisse co-funded research programs — reinforcing our mission to bridge clinical research and real-world healthcare through innovation.

We’re deeply grateful to ANI for their trust, and to our multidisciplinary teams in Switzerland, Portugal, and the UAE for their scientific rigor, technological excellence, and commitment to patient-centric innovation.

This milestone marks the next chapter of our expansion — enabling stronger academic and hospital partnerships, accelerating pilot studies in epilepsy, cardiology, diabetes, and oncology, and driving global regulatory readiness for our platform.

🌍 Together, we continue shaping the future of connected clinical research.

02/09/2025

You really want to invest your money with big returns in 3 years? Just check our investment deck and message us if you want to know more about 👌

Decentralized Clinical Trials (DCT) & Remote Patient Monitoring (RPM) Compliance. Data Integrity. Patient-Centric Trials.

23/08/2025

21/08/2025

🌍 At Vitruvian Shield SA, we believe the future of clinical research lies in decentralization, compliance, and patient-centric technology.

Today, our platform is fully ALCOA++ compliant, empowering health institutions to run studies with integrity and regulatory-grade reliability.

We are proud to already support 6 concrete use cases that research teams can adopt immediately:

✅ Short-Term Clinical Studies – fast pilots & feasibility projects
✅ Long-Term Observational Research – chronic disease monitoring over months
✅ Academic Research Programs – 3-month free access for universities & hospitals
✅ Patient Engagement & Self-Reporting – combining subjective and objective data
✅ Digital Biomarker Development – turning wearable signals into predictive insights
✅ Regulatory-Grade Data Repository – audit-ready datasets for CROs & sponsors

💡 Whether you are a hospital, CRO, or academic institution, Vitruvian Shield helps you collect continuous, compliant, and meaningful data that accelerates innovation in digital health.

🚀 And now a big step forward:
👉 Starting 1 September, you will be able to subscribe and begin testing directly on our website.

📣 Academic institutions: get three months of free access to Vitruvian Shield and accelerate your research today.

Let’s shape the future of healthcare research together.

12/08/2025

https://www.eubusinessnews.com/winners/vitruvian-shield-sa-2/
We proud of this new award 💪✨✨✨

Vitruvian Shield Sa is one of the 2025 winners of European CEO of the Year Awards.

02/08/2025

🚀 Meet the Future of Medication Management – In Your Pocket 💊📱

With the Vitruvian Shield SA mobile app, managing medications and prescriptions has never been easier — or friendlier. Designed with both patients and clinicians in mind, our intuitive UI ensures seamless access to:

✅ Digital prescriptions
✅ Smart medication reminders
✅ Real-time treatment updates
✅ Integrated alerts for interactions or missed doses

Whether you’re in the city or a remote village, our app keeps your treatment path clear, organized, and connected to your care team — securely and in real-time.

Because good health starts with good support. 💙

17/07/2025

🌍 Because clinical research should never be out of reach.

With Vitruvian Shield SA , patients in remote villages or busy cities stay connected to their medical team — not just by data, but by voice, text, and video. Day or night, someone is there. Someone listens.

For CROs, this means more than compliance. It means building trust, improving retention, and reaching people who were once left out of clinical studies.

Our platform brings together remote monitoring, CTMS, and AI-powered support in one secure environment — made for the real world.
Less site burden. More meaningful connections. Better outcomes.

Let’s bring clinical research closer to life. Together.

09/07/2025

🌐 Revolutionizing Health. Anywhere. Anytime.
With Vitruvian Shield, clinical research and remote care go hand-in-hand. Our all-in-one platform and mobile app bring clinical trial management, real-time vital sign monitoring, and 24/7 patient support to the palm of your hand.

📲 From hospital wards to remote villages, patients stay connected, safe, and empowered.
💡 For clinicians, it's smart insights. For patients, it’s peace of mind.

AI-powered. GDPR-ready. Built for the future of decentralized care.
Discover how we’re making health more human — and more intelligent.

🔗 Learn more at www.vitruvianshield.com

30/06/2025

**Epilepsy research needs more than snapshots—it needs stories told in real time.**

Vitruvian Shield is changing the game by capturing every heartbeat, movement, and signal linked to seizures through wearable tech and AI. From hospital to home, we bring precision and dignity to epilepsy trials—unlocking new biomarkers and a future of predictive care.

Smart, decentralized, and human-centered.
This is how we revolutionize epilepsy care.

\

Biomarker Discovery for Focal Seizures A revolutionary approach to transform how we understand and treat epilepsy through continuous, real-time monitoring and AI-powered analysis.

26/06/2025

Vitruvian Shield SA 2025 WINNER JULY 1